4
Changes in Ownership
AMARIN CORP PLCUK Filed Acc 0001562180-21-000880
Chief Scientific Officer sold 217,728 shares at an average $8.06 ($1,754,134)
- Chief Scientific Officer acquired 192,358 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ketchum Steven B · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 1 in the form | +16,703 | $2.50 | $41,758 | 425,069 | D |
| 2021-02-01 | Exercise or conversion : show line 2 in the form | +164,573 | $2.50 | $411,433 | 589,642 | D |
| 2021-02-01 | Exercise or conversion : show line 3 in the form | +11,082 | $2.95 | $32,692 | 600,724 | D |
| 2021-02-01 | Sale : show line 4 in the form | −192,358 | $8.06 | $1,550,463 | 408,366 | D |
| 2021-02-01 | Sale : show line 5 in the form | −25,370 | $8.03 | $203,670 | 382,996 | D |
| Open-market sales · 217,728 sh · avg $8.06 · $1,754,134 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −16,703 | 0 | D |
| 2021-02-01 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −164,573 | 0 | D |
| 2021-02-01 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −11,082 | 0 | D |
Loading xslF345X03/primarydocument.xml…